These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26355062)

  • 1. Increased Use Of Prescription Drugs Reduces Medical Costs In Medicaid Populations.
    Roebuck MC; Dougherty JS; Kaestner R; Miller LM
    Health Aff (Millwood); 2015 Sep; 34(9):1586-93. PubMed ID: 26355062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescription drugs: issues of cost, coverage, and quality.
    Copeland C
    EBRI Issue Brief; 1999 Apr; (208):1-21. PubMed ID: 10539445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization and costs of medical services and prescription medications for rheumatoid arthritis among recipients covered by a state Medicaid program: a retrospective, cross-sectional, descriptive, database analysis.
    Khanna R; Smith MJ
    Clin Ther; 2007 Nov; 29(11):2456-67. PubMed ID: 18158087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicaid prescription drug utilization and expenditures following Part D.
    Farley JF; Dusetzina SB
    J Health Care Poor Underserved; 2010 May; 21(2):715-28. PubMed ID: 20453368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Has The Era Of Slow Growth For Prescription Drug Spending Ended?
    Aitken M; Berndt ER; Cutler D; Kleinrock M; Maini L
    Health Aff (Millwood); 2016 Sep; 35(9):1595-603. PubMed ID: 27605638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in prescription drug expenditures by Medicaid enrollees.
    Banthin JS; Miller GE
    Med Care; 2006 May; 44(5 Suppl):I27-35. PubMed ID: 16625061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing prescribing patterns and increasing prescription expenditures in Medicaid.
    Fink KS; Byrns PJ
    Ann Fam Med; 2004; 2(5):488-93. PubMed ID: 15506586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recreational marijuana legalization and prescription opioids received by Medicaid enrollees.
    Shi Y; Liang D; Bao Y; An R; Wallace MS; Grant I
    Drug Alcohol Depend; 2019 Jan; 194():13-19. PubMed ID: 30390550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicaid prescription limits: policy trends and comparative impact on utilization.
    Lieberman DA; Polinski JM; Choudhry NK; Avorn J; Fischer MA
    BMC Health Serv Res; 2016 Jan; 16():15. PubMed ID: 26772962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations for Lowering Prescription Drug Spending in Public Programs.
    Jazowski SA; Dusetzina SB
    Ann Intern Med; 2019 Dec; 171(11):855-856. PubMed ID: 31711129
    [No Abstract]   [Full Text] [Related]  

  • 11. Medicaid prescription drug spending in the 1990s: a decade of change.
    Baugh DK; Pine PL; Blackwell S; Ciborowski G
    Health Care Financ Rev; 2004; 25(3):5-23. PubMed ID: 15229993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outpatient prescription drug utilization and expenditure patterns of noninstitutionalized aged Medicare beneficiaries.
    LaVange LM; Silverman HA
    Natl Med Care Util Expend Surv B; 1987 Apr; (12):1-43. PubMed ID: 10313516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Share Of Specialty Drugs In Commercial Plans Nearly Quadrupled, 2003-14.
    Dusetzina SB
    Health Aff (Millwood); 2016 Jul; 35(7):1241-6. PubMed ID: 27385240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug utilization and cost in a Medicaid population: a simulation study of community vs. mail order pharmacy.
    Valluri S; Seoane-Vazquez E; Rodriguez-Monguio R; Szeinbach SL
    BMC Health Serv Res; 2007 Jul; 7():122. PubMed ID: 17663768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of cost sharing on specialty drug utilization and outcomes: a review of the evidence and future directions.
    Doshi JA; Li P; Ladage VP; Pettit AR; Taylor EA
    Am J Manag Care; 2016 Mar; 22(3):188-97. PubMed ID: 27023024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Out-of-pocket health spending by poor and near-poor elderly Medicare beneficiaries.
    Gross DJ; Alecxih L; Gibson MJ; Corea J; Caplan C; Brangan N
    Health Serv Res; 1999 Apr; 34(1 Pt 2):241-54. PubMed ID: 10199672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of Medicare Part D and nondrug medical spending for elderly adults with limited prior drug coverage.
    McWilliams JM; Zaslavsky AM; Huskamp HA
    JAMA; 2011 Jul; 306(4):402-9. PubMed ID: 21791689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Medicare Part D for Medicare-age adults with arthritis: prescription use, prescription expenditures, and medical spending from 2005 to 2008.
    Cheng LI; Rascati KL
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1423-9. PubMed ID: 22508663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicare Part D: Patients Bear The Cost Of 'Me Too' Brand-Name Drugs.
    Gastala NM; Wingrove P; Gaglioti A; Petterson S; Bazemore A
    Health Aff (Millwood); 2016 Jul; 35(7):1237-40. PubMed ID: 27385239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in Medicaid prescription drug utilization and payments, 1990-97.
    Baugh DK; Pine PL; Blackwell S
    Health Care Financ Rev; 1999; 20(3):79-105. PubMed ID: 10558022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.